Last reviewed · How we verify
NCT05892861
The Effect of Multidomain Dietary Education in Type 2 Diabetic Adults
NA trial testing cognitive stimulation in Type2 Diabetes Mellitus in 40 participants. Completed in 31 March 2023.
31 December 2022
Quick facts
| Lead sponsor | National Kaohsiung Normal University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 3 June 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- cognitive stimulation
- as usual care
Conditions studied
- Type2 Diabetes Mellitus — all drugs for Type2 Diabetes Mellitus →
- Cognitive Impairment, Mild — all drugs for Cognitive Impairment, Mild →
Sponsor
National Kaohsiung Normal University
Who can join
20 and older, any sex, with Type2 Diabetes Mellitus or Cognitive Impairment, Mild. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to \[learn about cognitive stimulation by multidomain dietary education including the dietary board game via LINE in non-dementic type 2 diabetic adults. The main questions it aims to answer are: \[Question 1: Could multi-domain dietary education as cognitive stimulation improve cognitive function?\] \[Question 2: Could multi-domain dietary education improve dietary control belief ?\] \[Question 3: Could multi-domain dietary education improve health behavior?\] \[Question 4\]: Could multi-domain dietary education improve HbA1C, and lipid profile? Participants of experimental A group will receive a video about lifestyle education 5 minutes weekly for 3 weeks, a dietary board game 10 minutes weekly for 10 weeks, and a 24-hour dietary recall record 2 times weekly for 7 weeks. And participants of the experimental B group receive the usual clinical treatment. Then experimental A and Experimental B groups will cross over 12 weeks later. Researchers will compare the effect of intervention between the experimental A group and the experimental B group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05892861
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cognitive stimulation
Trials testing the same drug.
- NCT06801171 — A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders · NA · recruiting
- NCT06562387 — tDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With Depression · NA · active not recruiting
- NCT06572657 — Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A · NA · completed
- NCT05304975 — Border Region Area Lifestyle Intervention Study for Healthy Neurocognitive Ageing Diabetes · NA · completed
- NCT04184375 — Cognitive Stimulation for Elderly Bipolar Patients · NA · recruiting
Other recruiting trials for Type2 Diabetes Mellitus
Currently open trials in the same condition.
- NCT07533604 — SnapDandCGMinType2Diabetes · NA · recruiting
- NCT06961019 — Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets · NA · recruiting
- NCT06497842 — Effort During Resistance Training in Type 2 Diabetes · NA · active not recruiting
- NCT06257966 — A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type · Phase 3 · active not recruiting
- NCT03647306 — Behavioral Chronotype: Impact on Sleep and Metabolism · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05892861 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Kaohsiung Normal University
- Last refreshed: 11 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05892861.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing